LH stock: buy or sell?

LH stock price: $189.62 0.43% At close on February 21st, 2020

Updated on:
February 21st, 2020

0

After reaching all time highs on February/13, Laboratory Corporation of America inched 0.43% to $189.62.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates through two segments, LabCorp Diagnostics and Covance Drug Development.

Should I buy LH stock?

Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best moment to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

Currently, Laboratory Corporation of America stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean LH will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is Laboratory Corporation of America stock a buy?

Financial institutions and banks post stock ratings everyday. Unfortunately, we couldn't detect any rating for LH stock for the last 30 days.

LH stock analysis

Daily outlook

Laboratory Corporation of America inched 0.43% to $189.62 after marking all time highs on Feb 13th.

On Feb 13th, LH hit a new all time high, pushing higher than tops. Check different trading setups that use ATHs as triggers. After reaching all time highs on February/13, Laboratory Corporation of America inched 0.43% today to $189.62. From a daily perspective, LH is in a short term uptrend after plotting its last bottom ($181.99, on February/10) higher than the previous bottom, and its last top ($196.36, on Feb 13th) also over the previous top. Now trading in between its last bottom and last top LH might consolidate in a plain range, waiting to break out over $196.36 or down under $181.99. On January LH price bounced up over the SMA of 100 days demonstrating to be a significant support for this stock. Since SMA50d and SMA100d crossed up on December, LH price climbed $22.20 per share (13.26%).

LH stock chart (daily)

Weekly outlook

After boosting a dazzling 6.63% in a week last week, Laboratory Corporation of America closed this week at $189.62 and slipped a tragic -2.90%.

Not so far away is the last all-time high Laboratory Corporation of America marked last week. Laboratory Corporation of America stock is trading in the range of its last top and last bottom. Loosing would mean breaking the current uptrend. Breakdowns under last bottom are selling point signals for some trading strategies. Since early January when LH stock price broke up the SMA40w line, it gained $22.39 (13.39%). Since early June 2019 when SMA20w and SMA40w crossed up, LH price gained $27.01 per share (16.61%).

LH stock chart (weekly)

LH stock price history

LH stock went public on March 30th, 1990 with a price of $28.251. Since then, LH stock surged a 571.20%, with an average of 19.70% per year. If you had invested right after LH's IPO a $1,000 in LH stock in 1990, it would worth $5,712.00 today.

1: Adjusted price after possible price splits or reverse-splits.

LH stock historical price chart

LH stock reached all-time highs on February/13 with a price of $196.36.

LH stock price target

Nobody can reliably foresee how stock prices may evolve in the future. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' LH stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we have not found any price target for Laboratory Corporation of America stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

After publishing its last earnings report , Laboratory Corporation of America . Unfortunately, reported EPS is not yet available in our database.
LH earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q2-n/a2.07n/a
2017-Q32017-10-252.392.462.9%
2017-Q42018-02-062.382.452.9%
2018-Q12018-04-252.642.785.3%
2018-Q22018-07-252.922.982.1%
2018-Q32018-10-242.872.74-4.5%
2018-Q42019-02-072.482.521.6%
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a
2019-Q3-n/an/an/a

Annual financial results

In 2018, Laboratory Corporation of America annual sales soared a cool 9.95% to $11,333.40 M USD from $10,308.00 marked in 2017. Instead, its profit margin (compared to sales) declined to 7.80%, that is $883.70 million.

LH annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$5,810 M-$574 M9.9%-
2014$6,012 M3.47%$511 M8.5%-10.91%
2015$8,680 M44.39%$437 M5.0%-14.53%
2016$9,642 M11.08%$732 M7.6%67.57%
2017$10,308 M6.91%$1,227 M11.9%67.61%
2018$11,333 M9.95%$884 M7.8%-27.98%

Quarterly financial results

Laboratory Corporation of America reported $2,787.50 million in revenues for 2018-Q4, a -1.55% less compared to previous quarter. Reported quarter income marked $157.90 M with a profit margin of 5.66%. Profit margin dropped a -5.60% compared to previous quarter when profit margin was 11.26%. When comparing sales to same quarter last year, Laboratory Corporation of America sales marked a disappointing drop down and depreciated a -3.15%. Looking back to recent quarterly results, Laboratory Corporation of America posted 2 negative quarters in a row.
LH quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q2$2,540 M-$189 M7.4%-
2017-Q3$2,660 M4.72%$181 M6.8%-4.24%
2017-Q4$2,878 M8.20%$729 M25.3%303.60%
2018-Q1$2,848 M-1.04%$173 M6.1%-76.24%
2018-Q2$2,866 M0.63%$234 M8.2%34.99%
2018-Q3$2,831 M-1.22%$319 M11.3%36.36%
2018-Q4$2,788 M-1.55%$158 M5.7%-50.47%
2019-Q1$2,791 M0.13%$186 M6.6%17.54%

Laboratory Corporation of America ownership

When you are planning to buy shares of a company, it's always worth to overview its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Laboratory Corporation of America, 0.58% of all outstanding shares are owned by its staff.

Bearish positions for LH stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to Laboratory Corporation of America:

LH
Market cap$18.4 B
Total shares97.1 M
Float shares96.5 M
  - Institutional holdings (%)94.0%
  - Insider holdings (%)0.6%
Shares in short selling0.0%

LH summary

Friday, February 21st, 2020
Open$187.97
Close$189.62
Day range$187.68 - $189.90
Previous close$188.81
Session gain0.43%
Average true range$3.58
50d mov avg$176.85
100d mov avg$172.42
200d mov avg$170.53
Daily patternlt06a
Weekly pattern lt06a

Laboratory Corporation of America performance

To better understand Laboratory Corporation of America performance you must compare its gains with other related stocks in same sector or industry. We selected as the bechmarking frame for Laboratory Corporation of America stock.
Stock3m6m12m
LHLaboratory Corpor...11.70%14.33%27.47%

Laboratory Corporation of America competitors

Unfortunately, we could not find any public company that could be defined as Laboratory Corporation of America competitor. This doesn't mean Laboratory Corporation of America does not have any competitor in the market, it's just we could not detected it.

    Latest LH stock news